Home/Filings/4/0001746473-24-000016
4//SEC Filing

Hull Hans 4

Accession 0001746473-24-000016

CIK 0001746473other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:57 PM ET

Size

10.9 KB

Accession

0001746473-24-000016

Insider Transaction Report

Form 4
Period: 2024-01-23
Hull Hans
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-23+63,00063,000 total
    Exercise: $17.44Exp: 2034-01-23Common Stock (63,000 underlying)
  • Award

    Common Stock

    2024-01-23+31,500216,569 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    3,821
  • Common Stock

    (indirect: See footnote)
    13,985
  • Common Stock

    (indirect: See Footnote)
    13,985
Footnotes (5)
  • [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
  • [F2]The shares are held by The Sloger Hull Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The shares are held by a trust for the Reporting Person's minor child ("Child A Trust"). The Reporting Person and his spouse serve as trustees for Child A Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]The shares are held by a trust for the Reporting Person's minor child ("Child B Trust"). The Reporting Person and his spouse serve as trustees for Child B Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F5]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001614876

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:57 PM ET
Size
10.9 KB